AstraZeneca Shares Fall on Crestor Worry  LONDON (Reuters) - Shares in AstraZeneca Plc fell as much  as 10 percent on Friday after regulators in the United States  and Europe raised safety concerns about the Anglo-Swedish drug  maker's anti-cholesterol treatment Crestor.